Interventions to improve benzodiazepine tapering success in the elderly: a systematic review

References

• Baillargeon, L., Landreville, P., Verreault, R., Beauchemin, J. P., & Morin, C. M. (2003). Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: A randomized trial. Canadian Medical Association Journal, 169(10), 1015–1020. doi:10.1053/SMRV.2002.0274
   PubMed Web of Science ®Google Scholar
• Benzodiazepine use in British Columbia: Is it consistent with recommendations? (2005). Canadian Family Physician, 51(4), 514. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1472944/
   PubMedGoogle Scholar
• Bélanger, L., Morin, C. M., Bastien, C., & Ladouceur, R. (2005). Self-efficacy and compliance with benzodiazepine taper in older adults with chronic insomnia. Health Psychology, 24(3), 281–287. doi:10.1037/0278-6133.24.3.281
   PubMed Web of Science ®Google Scholar
• Caetano, P. A., Raymond, C. B., Morgan, S., & Yan, L. (2006). Income-based drug coverage in British Columbia: The impact on access to medicines. Healthcare Policy, 2(2), e154–e169. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585444/
   PubMedGoogle Scholar
• Canadian Centre on Substance Abuse (2014, November). Effective interventions to manage symptoms of benzodiazepine withdrawal in seniors, 1–9.
   Google Scholar
• Dijk, D. J., & Cajochen, C. (1997). Melatonin and the circadian regulation of sleep initiation, consolidation, structure, and the sleep EEG. Journal of Biological Rhythms, 12(6), 627–635. doi:10.1177/074873049701200618
   PubMed Web of Science ®Google Scholar
• Garfinkel, D., Zisapel, N., Wainstein, J., & Laudon, M. (1999). Facilitation of benzodiazepine discontinuation by melatonin: A new clinical approach. Archives of Internal Medicine, 159(20), 2456–2460. doi:10.1001/archinte.159.20.2456
   PubMed Web of Science ®Google Scholar
• Gould, R. L., Coulson, M. C., Patel, N., Highton-Williamson, E., & Howard, R. J. (2014). Interventions for reducing benzodiazepine use in older people: Meta-analysis of randomised controlled trials. British Journal of Psychiatry, 204(2), 98–107. doi:10.1192/bjp.bp.113.126003
   PubMed Web of Science ®Google Scholar
• Higgins, J. P. T., Altman, D. G., Gøtzsche, P. C., Jüni, P., Moher, D., Oxman, A. D., & Sterne, J. A. C. (2011). The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. British Medical Journal, 343, d5928. Retrieved from http://www.bmj.com/content/343/bmj.d5928.abstract
   PubMed Web of Science ®Google Scholar
• Kahan, M., Mailis-Gagnon, A., Wilson, L., & Srivastava, A. (2011). Canadian guideline for safe and effective use of opioids for chronic noncancer pain: Clinical summary for family physicians. Part 1: General population. Canadian Family Physician, 57(11), 1257–1266. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215602/
   PubMed Web of Science ®Google Scholar
• Karanicolas, P. J., Farrokhyar, F., & Bhandari, M. (2010). Blinding: Who, what, when, why, how ? Canadian Journal of Surgery, 53(5), 345–348. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947122/
   PubMed Web of Science ®Google Scholar
• Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M. & Canadian Anxiety Guidelines Initiative Group (2014). Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry, 14(Suppl 1), S1. doi:10.1186/1471-244X-14-S1-S1
   PubMed Web of Science ®Google Scholar
• Laudon, M., & Frydman-Marom, A. (2014). Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders. International Journal of Molecular Sciences, 15(9), 15924–15950. doi:10.3390/ijms150915924
   PubMed Web of Science ®Google Scholar
• Lähteenmäki, R., Puustinen, J., & Vahlberg, T. (2014). Melatonin for sedative withdrawal in older patients with primary insomnia: A randomized double-blind placebo-controlled trial. British Journal of Clinical Pharmacology, 77(6), 975–985. doi:10.1111/bcp.12294
   PubMed Web of Science ®Google Scholar
• Nakao, M., Takeuchi, T., Nomura, K., Teramoto, T., & Yano, E. (2006). Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic. Psychiatry and Clinical Neurosciences, 60(5), 605–610. doi:10.1111/j.1440-1819.2006.01565.x
   PubMed Web of Science ®Google Scholar
• Rapid Response Team (2015). Discontinuation Strategies for Patients with long-term benzodiazepine use: a review of clinical evidence and guidelines (pp. 1–9). Canada: Canadian Agency for Drugs and Technologies in Health.
   Google Scholar
• Schweizer, E., Case, W. G., Garcia-Espana, F., Greenblatt, D. J., & Rickels, K. (1995). Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: Effects on withdrawal severity and taper outcome. Psychopharmacology, 117, 424–429.
   PubMed Web of Science ®Google Scholar
• Tannenbaum, C., Martin, P., Tamblyn, R., Benedetti, A., & Ahmed, S. (2014). Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: The EMPOWER cluster randomized trial. JAMA Internal Medicine, 174(6), 890–898. doi:10.1001/jamainternmed.2014.949
   PubMed Web of Science ®Google Scholar
• Tannenbaum, M. D. (2015). Inappropriate benzodiazepine use in elderly patients and its reduction. Journal of Psychiatry & Neuroscience, 40(3), E27–E28. doi:10.1503/jpn.140355
   PubMed Web of Science ®Google Scholar
• Vicens, C., Bejarano, F., Sempere, E., Mateu, C., Fiol, F., Socias, I., … Leiva, A. (2014). Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: Cluster randomised controlled trial in primary care. British Journal of Psychiatry, 204(6), 471–479. doi:10.1192/bjp.bp.113.134650
   PubMed Web of Science ®Google Scholar
• Vicens, C., Fiol, F., Llobera, J., Campoamor, F., Mateu, C., Alegret, S., & Socías, I. (2006). Withdrawal from long-term benzodiazepine use: Randomised trial in family practice. British Journal of General Practice, 56(533), 958–963. doi:10.3399/bjgp11×549018
   PubMed Web of Science ®Google Scholar
• Vissers, F. H. J. A., Knipschild, P. G., & Crebolder, H. F. J. M. (2007). Is melatonin helpful in stopping the long-term use of hypnotics? A discontinuation trial. Pharmacy World and Science, 29(6), 641–646. doi:10.1007/s11096-007-9118-y
   PubMed Web of Science ®Google Scholar
• Voshaar, R. C. O., Gorgels, W. I., & Zitman, F. G. (2003). Tapering off long-term benzodiazepine use with or without group cognitive–behavioural therapy: Three-condition, randomised controlled trial. The British Journal of Psychiatry, 182(6), 498–504. Retrieved from http://bjp.rcpsych.org/content/182/6/498.abstract
   PubMedGoogle Scholar
• Weymann, D., Gladstone, E. J., Smolina, K., & Morgan, S. G. (2017). Long-term sedative use among community-dwelling adults: A population-based analysis. CMAJ Open, 5(1), E52–E60. doi:10.9778/cmajo.20160056
   PubMedGoogle Scholar
• Wick, J., 538–548(11) (2013). The history of benzodiazepines. The Consultant Pharmacist : The Journal of the American Society of Consultant Pharmacists, 28. doi:10.4140/TCP.n.2013.538
   PubMedGoogle Scholar